NEWS IN BRIEF

Alcami supporting commercial supply of Flexion’s first FDA-approved product

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/svengine)
(Image: Getty/svengine)
Alcami began work on Flexion Therapeutics's ZILRETTA in the fall of 2014 and today announced that it will further support commercial supply of the product, which is approved for the treatment of OA-related knee pain.

The contract development and manufacturing organization (CDMO) is expanding deployment of its “Extended Workbench” for the continuing manufacturing and development of ZILRETTA (triamcinolone acetonide extended-release injectable suspension).

Flexion initially used Alcami's ​“Extended Workbench” – a full-time equivalent (FTE) service program – to support Phase II clinical trials through commercial launch. Moving forward, the MA-based biopharmaceutical company will use the program for release and stability testing of commercial batches.

ZILRETTA is Flexion’s the first US Food and Drug Administration (FDA) approved product and was approved for the treatment of OA-related knee pain on October 6, 2017. It officially launched nationwide in late November of 2017.

"Our versatile Extended Workbench solution was an excellent fit for our partners at Flexion, whose accelerated timeline, robust clinical trial program, and specific testing requirements mandated dedicated laboratory resources to get their product to market,"​ said Alcami Chief Commercial Officer, Syed T. Husain in a press release.

Related news

Show more

Related products

show more

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Formedix | 09-Jun-2021 | Technical / White Paper

This article explains the different types of clinical trial software available, and how it can be used to optimize the end to end clinical trials design...

Integrated Solutions for Accelerated Time to Market

Integrated Solutions for Accelerated Time to Market

Piramal Pharma Solutions | 08-Jun-2021 | Technical / White Paper

Facing capacity constraints? Lock in your program now! With 14 sites around the world providing diverse services ranging from discovery to drug substance...

Adapting supply chains to new ways of working

Adapting supply chains to new ways of working

World Courier | 01-Jun-2021 | Technical / White Paper

COVID-19 has changed the way we operate. We have adapted our supply chain solutions to meet our clients’ requirements while following World Courier standard...

What are the building blocks of DCTs?

What are the building blocks of DCTs?

Medable | 26-Apr-2021 | Technical / White Paper

How to create a seamless experience across eConsent, eCOA and more.

Over the past year, tremendous progress was made toward digitizing and...

Related suppliers

Follow us

Products

View more

Webinars